Abstract
There is provided an ex-vivo insect screening model to accurately determine blood-brain barrier penetration of different nanoparticles in order to improve the compound screening procedures/processes in the early drug discovery process. This object offers many advantages relative to prior technologies since insect models are more reliable tools for the decision-making process than the existing in vitro models, and will speed up the drug screening process and reduce the late phase attrition rate. Moreover, it will reduce the number of mammals sacrificed during the drug discovery phase.
Claims
- A method of conducting blood-brain barrier penetration studies of nanoparticles in an insect, said method comprising the steps:
- · optionally anesthetizing the insect;
- • fixing the head of the insect;
- • dissecting out the dorsal part of the insect head so as to expose the brain, eyes, antennas, and nerve associations;
- • optionally removing the neural lamella;
- · treating the brain with the nanoparticles;
- • washing and homogenising or ultra sound disintegrating the brain; and
- • determining the concentration of the nanoparticles in the homogenised brain material. 2. The method of claim"! , wherein the penetration of the nanoparticles through the blood-brain barrier is calculated.
- The method of claim 1 or 2, wherein hemolymph and/or albumin is added to the nanoparticles.
- The method of any one of the claims 1 -3, wherein the concentration of the nanoparticle is determined by LC/MS.
- The method of any one of the claims 1-4, wherein the brain is treated with the nanoparticles for a period of 1 min to 2 days.
- The method of any one of the claims 1-5, wherein the neural lamella of the brain are removed before the brain is homogenised or ultra sound disintegrated.
Applicants
-
Entomopharm
Explore more patents:
-
Aadal Nielsen Peter
Explore more patents:
-
Andersson Gunnar
Explore more patents:
-
Andersson Olga
Explore more patents:
Inventors
-
Aadal Nielsen Peter
Explore more patents:
-
Andersson Gunnar
Explore more patents:
-
Andersson Olga
Explore more patents:
CPC Classifications
-
G01N33/5058
Explore more patents:
-
G01N33/5085
Explore more patents:
IPC Classifications
-
G01N33/50
Explore more patents:
Document Preview
- Publication: May 3, 2012
-
Application:
Sep 30, 2011
DK 2011050367 W
-
Priority:
Oct 25, 2010
DK PA201000969 A